Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.
2.

Genotype and allele frequencies of drug-metabolizing enzymes and drug transporter genes affecting immunosuppressants in the Spanish white population.

Bosó V, Herrero MJ, Buso E, Galán J, Almenar L, Sánchez-Lázaro I, Sánchez-Plumed J, Bea S, Prieto M, García M, Pastor A, Sole A, Poveda JL, Aliño SF.

Ther Drug Monit. 2014 Apr;36(2):159-68. doi: 10.1097/FTD.0b013e3182a94e65.

PMID:
24232128
3.

Pharmacogenetic screening for polymorphisms in drug-metabolizing enzymes and drug transporters in a Dutch population.

Bosch TM, Doodeman VD, Smits PH, Meijerman I, Schellens JH, Beijnen JH.

Mol Diagn Ther. 2006;10(3):175-85.

PMID:
16771603
4.

Inter and intra-ethnic differences in the distribution of the molecular variants of TPMT, UGT1A1 and MDR1 genes in the South Indian population.

Umamaheswaran G, Krishna Kumar D, Kayathiri D, Rajan S, Shewade DG, Dkhar SA, Manjunath S, Ushakiran P, Reneega G, Ritushree K, Adithan C.

Mol Biol Rep. 2012 May;39(5):6343-51. doi: 10.1007/s11033-012-1456-8. Epub 2012 Feb 9.

PMID:
22318545
5.
6.

Comparison of genetic variation in drug ADME-related genes in Thais with Caucasian, African and Asian HapMap populations.

Jittikoon J, Mahasirimongkol S, Charoenyingwattana A, Chaikledkaew U, Tragulpiankit P, Mangmool S, Inunchot W, Somboonyosdes C, Wichukchinda N, Sawanpanyalert P, He Y, McLeod HL, Chantratita W.

J Hum Genet. 2016 Feb;61(2):119-27. doi: 10.1038/jhg.2015.115. Epub 2015 Oct 1.

PMID:
26423926
7.

Flavopiridol pharmacogenetics: clinical and functional evidence for the role of SLCO1B1/OATP1B1 in flavopiridol disposition.

Ni W, Ji J, Dai Z, Papp A, Johnson AJ, Ahn S, Farley KL, Lin TS, Dalton JT, Li X, Jarjoura D, Byrd JC, Sadee W, Grever MR, Phelps MA.

PLoS One. 2010 Nov 1;5(11):e13792. doi: 10.1371/journal.pone.0013792.

8.

Clinical pharmacogenetics and potential application in personalized medicine.

Zhou SF, Di YM, Chan E, Du YM, Chow VD, Xue CC, Lai X, Wang JC, Li CG, Tian M, Duan W.

Curr Drug Metab. 2008 Oct;9(8):738-84. Review.

PMID:
18855611
9.

Genetic epidemiology of pharmacogenetic variations in CYP2C9, CYP4F2 and VKORC1 genes associated with warfarin dosage in the Indian population.

Giri AK, Khan NM, Grover S, Kaur I, Basu A, Tandon N, Scaria V; Consortium IGV; INDICO, Kukreti R, Brahmachari SK, Bharadwaj D.

Pharmacogenomics. 2014 Jul;15(10):1337-54. doi: 10.2217/pgs.14.88.

PMID:
25155935
10.

Pharmacogenetics of drug metabolizing enzymes in Brazilian populations.

Cerda A, Hirata MH, Hirata RD.

Drug Metabol Drug Interact. 2014;29(3):153-77. doi: 10.1515/dmdi-2013-0067. Review.

PMID:
24744305
11.

Korean, Japanese, and Chinese populations featured similar genes encoding drug-metabolizing enzymes and transporters: a DMET Plus microarray assessment.

Yi S, An H, Lee H, Lee S, Ieiri I, Lee Y, Cho JY, Hirota T, Fukae M, Yoshida K, Nagatsuka S, Kimura M, Irie S, Sugiyama Y, Shin DW, Lim KS, Chung JY, Yu KS, Jang IJ.

Pharmacogenet Genomics. 2014 Oct;24(10):477-85. doi: 10.1097/FPC.0000000000000075.

PMID:
25029633
12.

[Genetic polymorphisms on drug metabolizing enzymes in relation to anti-cancer drug effectiveness].

Ozawa S.

Rinsho Byori. 2003 Feb;51(2):168-73. Review. Japanese.

PMID:
12690635
13.

Pharmacogenetics of antimalarial drugs: effect on metabolism and transport.

Kerb R, Fux R, Mörike K, Kremsner PG, Gil JP, Gleiter CH, Schwab M.

Lancet Infect Dis. 2009 Dec;9(12):760-74. doi: 10.1016/S1473-3099(09)70320-2. Review.

PMID:
19926036
14.

Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer.

Nebert DW, McKinnon RA, Puga A.

DNA Cell Biol. 1996 Apr;15(4):273-80. Review.

PMID:
8639263
15.

Influence of genomic ancestry on the distribution of SLCO1B1, SLCO1B3 and ABCB1 gene polymorphisms among Brazilians.

Sortica Vde A, Ojopi EB, Genro JP, Callegari-Jacques S, Ribeiro-Dos-Santos A, de Moraes MO, Romano-Silva MA, Pena SD, Suarez-Kurtz G, Hutz MH.

Basic Clin Pharmacol Toxicol. 2012 May;110(5):460-8. doi: 10.1111/j.1742-7843.2011.00838.x. Epub 2011 Dec 29.

16.

Genetic variation in metabolizing enzyme and transporter genes: comprehensive assessment in 3 major East Asian subpopulations with comparison to Caucasians and Africans.

Man M, Farmen M, Dumaual C, Teng CH, Moser B, Irie S, Noh GJ, Njau R, Close S, Wise S, Hockett R.

J Clin Pharmacol. 2010 Aug;50(8):929-40. doi: 10.1177/0091270009355161. Epub 2010 Feb 19.

PMID:
20173083
17.

Pharmacogenetics of membrane transporters: a review of current approaches.

Sissung TM, Goey AK, Ley AM, Strope JD, Figg WD.

Methods Mol Biol. 2014;1175:91-120. doi: 10.1007/978-1-4939-0956-8_6. Review.

PMID:
25150868
18.

Genetic predisposition to adverse drug reactions in the intensive care unit.

Empey PE.

Crit Care Med. 2010 Jun;38(6 Suppl):S106-16. doi: 10.1097/CCM.0b013e3181de09f8. Review.

PMID:
20502164
19.

Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy.

Bosch TM.

Methods Mol Biol. 2008;448:63-76. doi: 10.1007/978-1-59745-205-2_5. Review.

PMID:
18370231
20.

Interplay of pharmacogenetic variations in ABCB1 transporters and cytochrome P450 enzymes.

Yoo HD, Lee YB.

Arch Pharm Res. 2011 Nov;34(11):1817-28. doi: 10.1007/s12272-011-1104-1. Epub 2011 Dec 3. Review.

PMID:
22139683

Supplemental Content

Support Center